Mineshima Hiroshi | 論文著者

Drug Evaluation Committee, the Japan Pharmaceutical Manufacturers Association (JPMA)

Drug Evaluation Committee, the Japan Pharmaceutical Manufacturers Association (JPMA):Preclinical Development Department, Novartis Pharma K. K.

Drug Safety Research Laboratories Eisai Co. Ltd.

Drug Safety Research Laboratories, Eisai Co., Ltd.

Pathology, Tsukuba Research Institute, Novartis Pharma K. k.

Toxicology And Pathology Group Tsukuba Research Institute Novartis Pharma K.k.

Toxicology and Pathology group, Tsukuba Research Institute, Novartis Pharma K.K.

Toxicology/Pathology, Tsukuba Research Institute, Novartis Pharma K. K.

Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm